ImmunoPrecise Antibodies Ltd. (HYFT)
Market Closed
18 Sep, 20:00
NASDAQ (NMS) NASDAQ (NMS) Primary $
1. 36
+0.05
+3.8168%
$
63.9M Market Cap
- P/E Ratio
- Div Yield
287,400 Volume
- Eps
$ 1.31
Previous Close Investors:
Want to track HYFT and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
ImmunoPrecise Antibodies Ltd. (HYFT) Statistics
Valuation metrics
Market Cap 63.9M
Enterprise value 85.26M
Trailing P/E (ttm) -5.21
Forward P/E -
PEG ratio -0.18
Price/Sales (ttm) 5.52
Price/Book (mrq) 12.88
Enterprise Value/Revenue 5.27
Enterprise Value/EBITDA -5.12
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 178.75K
Average volume (90 days) 168.73K
Price summary
52-Week low 0.99
52-Week high 2.99
Beta -
50-Day moving average 1.35
200-Day moving average 1.33
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate -
Trailing annual dividend yield -
5-Year annual dividend yield -
Payout ratio -
Dividend Date -
Ex-Dividend Date -
Last split factor 1:5
Last split Date 23 Nov 2020
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin -1.05%
Operating margin -1.04%
Operational effectiveness
Return on assets -0.99%
Return on equity -1.44%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) 0.35
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -0.36
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 0.16
Total debt (mrq) -
Total Debt/Equity (mrq) 0.5
Current ratio (mrq) 1.84%
Book value per share (mrq) 0.15
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
